Key facts
- This page summarizes Jack Phillips's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Jul 2023, 17:11.
Jack Phillips - 13 Jul 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- AXDX
- Reported as of
- 13 Jul 2023
- Net transaction value
- -$5,030
- SEC form
- 4
- Accepted by SEC
- 17 Jul 2023, 17:11:37 UTC
- Prior SEC filing
- 10 Jul 2023
- Next SEC filing
- 15 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Patience, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jack Phillips filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 17 Jul 2023.
Change
- Previous filing in this sequence was filed on 10 Jul 2023.
- Current net transaction value: -$5,030.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXDX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,722
- Change %
- +3.2%
- Price
- $0.000000
- Shares after
- 55,358
- Date
- 13 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
AXDX
transaction
Common Stock
Sale
- Transaction value
- $5,030
- Shares
- -729
- Change %
- -1.3%
- Price
- $6.90
- Shares after
- 54,629
- Date
- 13 Jul 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXDX
transaction
Derivative
Employee Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,722
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 8,607
- Date
- 13 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,722
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.
Footnote F2
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
SEC remarks
On July 11, 2023, the issuer effected a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, proportionate adjustments were made to the number of shares of the issuer's common stock underlying its outstanding equity awards, warrants and convertible notes, as well as the exercise or conversion price, as applicable. The amounts reported herein (and to be reported in subsequent reports) have been adjusted to reflect the Reverse Stock Split.